Host cell targets for antiviral therapy:: an update

被引:4
作者
DeFilippis, Victor [1 ]
Frueh, Klaus [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
关键词
cholesterol pathway; endocytosis farnesyl; geranyl-geranyl; Gleevec((R)); small interfering; RNA; statin; therapeutic targets;
D O I
10.2217/17460794.1.4.509
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The discovery of antiviral therpeutic targets has traditionally focussed on conserved viral gene products. Since viruses are obligate molecular parasites requiring and manipulating host cell functions, the identification of host proteins essential to viruses but not cellular survival represent attractive and underutilized targets for antiviral therapies. Numerous studies have identified host cell functions, pathways and proteins that are essential for viral propagation, from entry to replication, assembly and egress. Importantly, several studies demonstrate virus inhibition through nonlethal impairment of host cell function both in vitro and in vivo. In addition, high-throughput experimental platforms allowing global or nearglobal surveillance of host gene products in the context of virus replication are now being used to systematically identify host cell targets. Recent breakthrough studies that have employed such methods successfully to identify host proteins and pathways crucial for virus growth are discussed in this review.
引用
收藏
页码:509 / 518
页数:10
相关论文
共 50 条
[41]   Monocytic microRNAs-Novel targets in atherosclerosis therapy [J].
Euler, Gerhild ;
Parahuleva, Mariana .
BRITISH JOURNAL OF PHARMACOLOGY, 2025, 182 (02) :206-219
[42]   Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy? [J].
N. Muvarak ;
P. Nagaria ;
F. V. Rassool .
Current Hematologic Malignancy Reports, 2012, 7 :94-102
[43]   Modulating undruggable targets to overcome cancer therapy resistance [J].
Passirani, Catherine ;
Vessieres, Anne ;
La Regina, Giuseppe ;
Link, Wolfgang ;
Silvestri, Romano .
DRUG RESISTANCE UPDATES, 2022, 60
[44]   Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy? [J].
Muvarak, N. ;
Nagaria, P. ;
Rassool, F. V. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (02) :94-102
[45]   Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense [J].
Xia, Xuhua .
MOLECULAR BIOLOGY AND EVOLUTION, 2020, 37 (09) :2699-2705
[46]   Role of RNA G-Quadruplexes in the Japanese Encephalitis Virus Genome and Their Recognition as Prospective Antiviral Targets [J].
Singh, Aakriti ;
Majee, Prativa ;
Mishra, Laxmi ;
Prajapat, Surendra Kumar ;
Sharma, Tarun Kumar ;
Kalia, Manjula ;
Kumar, Amit .
ACS INFECTIOUS DISEASES, 2024, 11 (03) :558-572
[47]   Antigenic targets for renal cell carcinoma immunotherapy [J].
Vieweg, J ;
Jackson, A .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (11) :1791-1801
[48]   Novel therapeutic targets for diabetes-related wounds or ulcers: an update on preclinical and clinical research [J].
Golledge, Jonathan ;
Thanigaimani, Shivshankar .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (12) :1061-1075
[49]   Hantaviruses use the endogenous host factor P58IPK to combat the PKR antiviral response [J].
Wang, Zekun ;
Ren, Songyang ;
Li, Qiming ;
Royster, Austin D. ;
Lin, Lei ;
Liu, Sichen ;
Ganaie, Safder S. ;
Qiu, Jianming ;
Mir, Sheema ;
Mir, Mohammad A. .
PLOS PATHOGENS, 2021, 17 (10)
[50]   Recent Advances in Gene Therapy for Familial Hypercholesterolemia: An Update Review [J].
Fu, Qingan ;
Hu, Lijuan ;
Shen, Tianzhou ;
Yang, Renqiang ;
Jiang, Long .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)